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ABSTRACT
Objective To assess the impact of different management
strategies in urinary tract infections.
Design Randomised controlled trial.
Setting Primary care.
Participants 309 non-pregnant women aged 18-70
presenting with suspected urinary tract infection.
Intervention Patients were randomised to five
management approaches: empirical antibiotics;
empirical delayed (by 48 hours) antibiotics; or targeted
antibiotics based on a symptom score (two or more of
urine cloudiness, urine smell, nocturia, or dysuria), a
dipstick result (nitrite or both leucocytes and blood), or a
positive result on midstream urine analysis. Self help
advice was controlled in each group.
Main outcome measures Symptom severity (days 2 to 4)
and duration, and use of antibiotics.
Results Patients had 3.5 days of moderately bad
symptoms if they took antibiotics immediately. There
were no significant differences in duration or severity of
symptoms (mean frequency of symptoms on a 0 to 6
scale: immediate antibiotics 2.15, midstream urine 2.08,
dipstick 1.74, symptom score 1.77, delayed antibiotics
2.11; likelihood ratio test for the five groups P=0.177).
There were differences in antibiotic use (immediate
antibiotics 97%, midstream urine 81%, dipstick 80%,
symptom score 90%, delayed antibiotics 77%; P=0.011)
and in sending midstream urine samples (immediate
antibiotics 23%, midstream urine 89%, dipstick 36%,
symptom score 33%, delayed antibiotics 15%; P<0.001).
Patients who waited at least 48 hours to start taking
antibiotics reconsulted less (hazard ratio 0.57 (95%
confidence interval 0.36 to 0.89), P=0.014) but on
average had symptoms for 37% longer than those taking
immediate antibiotics (incident rate ratio 1.37 (1.11 to
1.68), P=0.003), particularly the midstream urine group
(73% longer, 22% to 140%; none of the other groups had
more than 22% longer duration).
Conclusion All management strategies achieve similar
symptom control. There is no advantage in routinely
sending midstream urine samples for testing, and
antibiotics targeted with dipstick tests with a delayed
prescription as backup, or empirical delayedprescription,
can help to reduce antibiotic use.
Study registration National Research Register
N0484094184 ISRCTN: 03525333.
INTRODUCTION
Urinary tract infections are one of the most common
conditions seen in female patients in general practice.1.
These infections affect 50% of women at least once in
their lives,2 and more than 20% of infections are resis-
tant to trimethoprim and cephalosporins and 50% to
amoxicillin.
Urinary dipsticks are the most commonly used near
patient test in primary care in the United Kingdom.
The aim of using dipsticks is to target treatment to the
60%ofwomenwho have urinary tract infections,while
minimising antibiotic use forwomenwithout infection.
A previous validation study has shown that dipsticks
and clinical scoring algorithms can potentially help
improve the precision of diagnosis by improving the
positive predictive values.3 If clinicians are to use dip-
sticks, however, they need to have strategies to deal
with the poor negative predictive values.3 We know
of no trial that has assessed dipstick or clinical manage-
ment algorithms in comparison with the realistic alter-
natives. Previous studies have documented that
delayed antibiotic prescribing in respiratory infections
results in good symptom control, reduced belief in the
effectiveness of antibiotics, and fewer repeat
consultations.4-6 We hypothesised that, compared
with an immediate antibiotic prescription, other man-
agement strategies would result in worse symptom
control, particularly in women asked to delay anti-
biotics empirically or while waiting for the result of
midstream urine analysis.
We aimed to assess the effectiveness of management
using dipstick or clinical algorithms comparedwith the
alternative management strategies (empirical anti-
biotic treatment, delayed prescribing, and targeted
prescribing based on midstream urine results).
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METHODS
Non-pregnant womenwith a suspected uncomplicated
urinary tract infection (where antibiotic use was not
mandatory) were recruited on presentation between
June 2003 and September 2005 by 62 general practi-
tioners and nurses in the south of England. Patients
were excluded if immediate antibiotic treatment was
necessary (if they were pregnant, if they had pyelone-
phritis, nausea, vomiting, or other severe systemic
symptoms), if they were aged over 75 (in older people
symptoms of urinary tract infection might be reported
differently), or if they had psychosis or dementia or
needed terminal care (as such patients might have
been unable to complete the diary).
Data collection
The clinician documented baseline symptoms, clinical
information, and demographic details (age, sex, and
postcode). The patient kept a daily symptom diary,
grading severity—0 (no symptoms), 1 (a very slight
problem), 2 (a slight problem), 3 (a moderately bad
problem), 4 (a bad problem), 5 (a very bad problem),
or 6 (as bad as it could be). The symptoms—dysuria,
haematuria, frequency during day and night, “smelly
urine,” “tummy pain,” generally feeling unwell, and
restriction of daily activities—were based on the com-
mon presenting symptoms of urinary tract infection.7
The diary format was previously validated and shown
to be sensitive to change for other acute infections.8
There were also questions (Likert scales) on belief in
the effectiveness of antibiotics, which had good discri-
minant ability in previous studies,9 a self report
questionnaire of medically unexplained somatic
symptoms,10 and a list of other medical problems. To
help improve completeness of the diaries, patients
were phoned by the research assistant after three days
to check there were no problems with the diary. No
questions were asked about compliance or return to
the surgery, since this could have altered patient beha-
viour. Completed diaries were returned to the surgery
in a freepost envelope.
Laboratory analysis
Midstreamurine sampleswere transported as in routine
practice. European guidelines were used to document
significant bacteriuria, which allows laboratory confir-
mation of diagnosis based on lower colony counts,11
similar to the latest UK standards www.hpa-standard
methods.org.uk/documents/bsop/pdf/bsop41.pdf.
Randomisation
Patients were individually randomised within the con-
sultation to one of five basic management groups:
immediate antibiotics; delayed antibiotics; symptom
score (antibiotics offered if two ormore of urine cloudy
onexamination, urine offensive smell on examination,
patient’s report of moderately severe dysuria, or
patient’s report of nocturia); dipstick (antibiotics
offered if nitrites or leucocytes and a trace of blood
were detected); or midstream urine (symptomatic
treatment until microbiology results available and
then antibiotics targeted according to results) (see
appendix on bmj.com). Randomisation was done
with computer generated random number tables in
blocks to provide reasonably balanced group num-
bers. Patients were allocated by the opening of a sealed
numbered envelope containing the instruction sheets
for one of the five management groups. Sealed envel-
opes were used to facilitate randomisation and to
ensure that the sheets the clinician needed were imme-
diately to hand. The potential to undermine randomi-
sation was minimised by careful attention to
maximising equipoise when presenting the study to
clinicians, and by emphasising that women in all
groups had access to antibiotics at their request.
Sequential envelope use was also audited during the
study to ensure integrity of randomisation.
Since normal management of urinary tract infection
is to use immediate antibiotics, we judged that the con-
trol of self help advice in other groups was needed to
avoid a major imbalance. Self help advice—regarding
fluids, and the use of fruit juices, bicarbonate, and a self
help leaflet—was controlled for by randomisation in a
balanced factorial design (see appendix on bmj.com).
Use of advice sheets
For each patient, a structured advice sheet was used,
which supported the initial management according to
the proposed strategy— as used successfully in pre-
vious studies from this group.5 12-15 This study’s prag-
matic design allowed for variation according to
negotiation with patients, as would happen in
practice.5 Thus, although clinicians negotiated initial
antibiotic management based on the sheets, they
were allowed to provide immediate antibiotics in situa-
tions where there were strong patient expectations.
Conversely, provided the initial proposed manage-
ment was themanagement indicated by the sheet, doc-
tors and nurses had discretion to do a dipstick test or
order a midstream urine test—either negotiated
because of patient pressure or expectation or because
of clinical perceptions of the requirement for adequate
documentation of diagnosis.Health professionalswere
asked to document what they did in each case, and we
used this information in the analysis to assess whether
the results were confounded by such behaviour. We
did an in-depth review of 38 case notes with the health
professionals concerned in the largest recruiting prac-
tice to assess whymidstream urines and dipsticks were
used when not indicated by the advice sheets.
A research assistant independent of the trial team
and blinded to study group reviewed notes to docu-
ment use of midstream urine analysis, antibiotic pre-
scription, and referrals.
Sample size calculation
Calculation was done for α=0.05 and β=0.2 with the
NQuery sample size program for multiple groups.
On the basis of previous consensus decisions,13 a
small difference in symptoms was defined as, on
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average, one in twopatients rating symptoms as a slight
problem rather than a moderate problem (a difference
of 0.5 on the diary score). Based on the means and
standard deviation (SD) from the pilot study, assuming
the midstream urine and delayed groups had diary
scores 0.5 higher than those of the other groups in the
three days after seeing the doctor, a sample size of 260
patients was required, allowing for up to 20% loss to
follow-up.
We assessed the effect of management strategies
using multiple regression on an intention to treat
basis, mutually controlling for all interventions (Stata
version 9, StataCorp, College Station, TX). No inter-
action between self help advice and the basic manage-
ment strategies was found, so the main effects of the
basic management strategies are presented controlling
for self help advice.We used negative binomial regres-
sion for duration of symptoms (because of overdisper-
sion), multiple linear regression for the severity of
symptoms, logistic regression for antibiotic use and
repeat consultations, and Cox regression for time to
repeat consultation. Our primary assessment was of
the overall significance of the main intervention factor
using the likelihood ratio test. The estimates of most
interest are the comparison of each groupwith the con-
trol group (immediate antibiotics, the most common
management strategyused by clinicians).We therefore
report the estimate of differences compared with the
control group with their 95% confidence intervals.
We specified symptom severity as the primary out-
come a priori. A previous factor analysis of an observa-
tional cohort study demonstrated two groups of
symptoms: increased day frequency, increased night
frequency, and urgency and dysuria (“frequency”
symptoms; Cronbach’s α=0.77); and abdominal pain,
restricted activities, and feeling unwell (“unwell”
symptoms; α=0.80). The observational data suggested
that the severity “frequency symptoms”would bemost
likely to differ with alternative strategies and thus the
frequency score (presented as the mean score of all the
above items) was specified as the primary outcome.
Since the study was individually randomised we did
not control for practice or general practitioner in the
models (and controlling for general practitioner did
not alter the inferences).
RESULTS
Most general practitioners recruited few patients, cit-
ing lack of time as the major reason. Of those patients
invited, most accepted, and there was no difference in
characteristics of this patient group with those in other
observational studies.3 Therewere no important differ-
ences by management group for the key baseline vari-
ables of age, symptom severity, past cystitis, somatic
symptom inventory, and comorbidities (table 1).
Although marital status did differ slightly by group,
inclusion of this factor in the models did not confound
the estimates.
There were differences between groups where clin-
icians reported sending a midstream urine sample to
the laboratory at the index consultation (immediate
antibiotics 23% (15/66), midstream urine 89%
(48/54), dipstick 36% (21/58), symptom score 33%
(23/69), and delayed antibiotics 15% (9/62); χ2=81;
P<0.001). There were also differences in the number
where dipstick results were documented (immediate
antibiotics 50% (33/66), midstream urine 52%
(28/54), dipstick 95% (55/58), symptom score 55%
(38/69), delayed antibiotics 29% (18/62); χ2=55;
P<0.001). Including these variables in the models
(that is whether or not a midstream urine sample was
sent or a dipstick result documented) did not alter the
estimates of the main outcomes.
The detailed review and discussion of cases—where
dipstick documentation and midstream urine analysis
were not prompted by the advice sheets—confirmed
that subversion of protocol had probably not occurred.
The main reasons highlighted were: negotiation based
on patient expectation, professional perception of the
need for adequate documentation (dipstick results
being regarded as useful even if management was not
based on them), and occasionally clinical reasons (for
Table 1 | Baseline comparison of demographic and clinical characteristics of five main management groups. Figures are
means (SD) unless specified
Immediate antibiotics Midstream urine Dipstick Symptom Delayed antibiotics
Frequency symptom severity
at point of randomisation*
1.81 (0.61) 1.80 (0.78) 1.71 (0.70) 1.79 (0.70) 1.76 (0.71)
No (%) married 27/39 (69) 25/38 (66) 34/42 (81) 37/49 (76) 27/39 (69)
Age when left education (years) 17.9 (2.3) 17.0 (2.4) 17.8 (2.8) 17.5 (2.6) 17.5 (2.5)
Age (years) 43 (16) 41 (16) 43 (15) 45 (15) 39 (16)
No (IQR) of somatic symptoms† 3 (1-8) 4 (1-6) 4 (2-6) 3 (2-6) 4 (2-8)
No (IQR) of medical problems‡ 2 (1-8) 2 (1-6) 2 (1-6) 3 (1-6) 2.5 (1-8)
No (%) with previous cystitis 40/46 (87) 35/41 (85) 32/39 (82) 43/50 (86) 35/41 (85)
IQR=interquartile range.
*Mean of frequency symptoms at randomisation (daytime frequency, night frequency, dysuria); each symptom rated 0=no problem; 1=mild problem,
2=moderately bad problem, 3=severe problem.
†On modified version of somatic symptom inventory (SSI).10 Patients indicate number of medically unexplained symptoms severe enough to interfere
with normal life or which required seeing doctor.
‡List of major medical problems (such as, back pain, diabetes, arthritis, etc, and free space for other) documented by patients and number listed
counted.
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example, a higher risk of complication was expected; a
more definite initial diagnosis was required) were cited
for unprompted investigations.
Symptoms
The average duration of symptoms rated as moder-
ately bad or worse with immediate antibiotics was 3.
5 days. Overall, there were no significant differences
in symptomduration, severity of frequency symptoms,
or severity of unwell symptoms between the antibiotic
management strategies (table 2). The confidence inter-
vals for symptom severity were all, with the exception
of themidstreamurine group,within the limit of SD0.5
—the clinically important difference we specified a
priori. The confidence intervals here are particularly
helpful in showing that the estimates for the dipstick,
symptom, and delayed antibiotics groups are unlikely
to be 0.5 worse on the diary score—that is, unlikely to
do harm—which is what clinicians need to know if they
are considering changing from their current empirical
treatment strategy. Those women who delayed anti-
biotics for 48 hours or more, however, were likely to
have 37% longer duration of symptoms rated as mod-
erately bad (incidence rate ratio 1.37 (95% confidence
interval 1.11 to 1.68), P<0.001). The effect of delaying
more than 48 hours predominantly applied to themid-
stream urine group (likelihood ratio test for interaction
for the five groups P=0.08; formidstreamurine group v
the other groups P=0.02) (table 3). Women delayed
longest in both the midstream urine and the delayed
groups (the average day starting antibiotics was 1.19
for immediate antibiotics, 2.18 for midstream urine,
1.43 for dipstick testing, 1.40 for symptom score, and
2.21 for delayed antibiotics).
Use of antibiotics
Of women in the midstream urine group, 66% (36/54)
had a confirmed urinary tract infection. There were
significant differences in the number of women who
waited at least 48 hours before taking antibiotics
(immediate antibiotics 8% (5/60); midstream urine
43% (20/47); dipstick 30% (15/50), symptom score
19% (11/58), and delayed antibiotics 53% (28/53); χ2
34; P<0.001); also in the number taking antibiotics
(immediate antibiotics 97% (58/60), midstream urine
81% (38/47), dipstick 80% (40/50), symptom score
90% (52/58), delayed antibiotics 77% (41/53); χ2 11.7;
P=0.02). Women had similar beliefs in the effective-
ness of antibiotics (immediate antibiotics 72%
(44/61), midstream urine 74% (34/46), dipstick 79%
(37/47), symptom score 73% (41/56), delayed anti-
biotics 72% (36/50)).
Use of resources
There was little difference between groups for further
contacts recorded in the four weeks after consent
(immediate antibiotics 6/58 (10%), midstream urine
9/52 (17%), dipstick 6/51 (12%) symptom score 8/64
(13%), delayed antibiotics 5/58 (9%); P=0.79), nor use
of midstream urine analysis over the next month
(immediate antibiotics 3/58 (5%), midstream urine
3/52 (6%), dipstick 4/51 (8%), symptom score 5/64
(8%), delayed antibiotics 3/58 (5%) P=0.95). The aver-
age follow-up was 575 days (range 35 to 968). During
follow-up there was no overall difference in time to
reconsultation, but there was non-significant evidence
that repeat consultations might be reduced in the
delayed group (table 2).6 As some data for time to
first reconsultations were missing for Cox regression,
we also used more complete data to assess whether
reconsultation had occurred, controlling for time
between randomisation and notes review: in the
immediate antibiotics group 32/58 (55%) returned,
and other groups reconsulted less: midstream urine
odds ratio 0.65 (0.30 to 1.40); dipstick 0.87 (0.40 to
1.90); symptom score 0.57 (0.27 to 1.18); and delayed
0.44 (0.21 to 0.95). Patients who waited for at least 48
hours before using their prescription reconsulted less
(hazard ratio 0.57 (0.36 to 0.89); P=0.014). No major
adverse events (major illness, admission to hospital,
death) were reported for any group, and no significant
differences in skin rash or thrush were reported.
Table 2 | Effect on symptom duration, symptom severity for the two to four days after seeing the health professional, antibiotic use, and reconsultation
during follow-up*. Figures are means differences, incidence ratios, odds ratios, or hazard ratios with 95% confidence intervals
Mean frequency symptom†
severity (mean difference)
Duration ofmoderately bad
symptoms in days
(incidence ratio‡)
Mean unwell symptom§
severity (mean difference)
No (%) who used antibiotics
odds ratio)
Time to reconsultation
(hazard ratio)†
Immediate antibiotics 2.15 (SD 1.18) 1 1.60 (SD 1.30) 58/60 (97%) 1
Midstream urine 2.08 (−0.07; −0.51 to 0.37) 1.21 (0.92 to 1.61) 1.66 (0.05; −0.44 to 0.55) 81% (38/47), 0.15 (0.03 to 0.73) 0.81 (0.47 to 1.39)
Dipstick 1.74 (−0.40; −0.85 to 0.04) 0.91 (0.68 to 1.22) 1.32 (−0.28; −0.77 to 0.20) 40/50 (80%), 0.13 (0.03 to 0.63) 0.98 (0.58 to 1.65)
Symptom score 1.77 (−0.38; −0.79 to 0.04) 1.11 (0.85 to 1.44) 1.26 (−0.35; −0.80 to 0.11) 52/58 (90%), 0.29 (0.06 to 1.55) 0.73 (0.43 to 1.22)
Delayed antibiotics 2.11 (−0.04; −0.47 to 0.40) 1.12 (0.85 to 1.47) 1.43 (−0.18; −0.65 to 0.30) 41/53 (77%), 0.12 (0.03 to 0.59) 0.60 (0.35 to 1.05)
P (likelihood ratio test) 0.177 0.369 0.392 0.011 0.345
*All estimates are adjusted for self help advice given. Frequency symptoms are also adjusted for the estimate of severity of frequency symptoms at baseline.
Where differences are quoted, these are estimated differences compared with immediate antibiotics. Thus taking first row midstream urine group has mean frequency symptoms 0.07 lower
than immediate group, incidence rate ratio of 1.21 compared with immediate group (that is, 21% longer duration of symptoms), and unwell symptoms 0.05 higher than immediate group.
†Mean score for four items: increased day frequency, increased night frequency, urgency, and dysuria. Symptom severity: 0=no problem, 6=as bad as it could be.
‡For illustration, estimated duration of symptoms rated moderately bad or worse in groups based on mean of 3.54 days in immediate group and with incidence rate ratios, are 4.28 days for
midstream urine, 3.22 days for dipstick tests, 3.93 days for symptom score, and 3.96 days for delayed antibiotics.
§Mean score for three items: abdominal pain, restricted activities, and feeling unwell. Symptom severity: 0=no problem, 6=as bad as it could be.
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DISCUSSION
All five management strategies for managing urinary
tract infection in primary care achieved similar symp-
tom control, and we found no advantage in routinely
sending midstream urine samples for laboratory test-
ing. Antibiotic use targeted with dipstick testing with a
delayed prescription as backup or empirical delayed
prescription helped to reduce antibiotic use.
Potential limitations
Patients’ diary records for acute illness are likely to be
reliable, and supporting each strategy in a structured
manner minimises any differential placebo effects.5
Type I error is possible for the subgroup analyses
(which must be interpreted with caution), and type II
error is unlikely (we had complete results in 277 (90%)
patients so hadmore power than originally calculated).
There was no evidence from auditing the use of envel-
opes, nor from the baseline tables, that randomisation
was subverted. When there were modest differences
between advice groups, we tested for confounding
and found no evidence. In particular, although
frequency symptoms were slightly (though not signifi-
cantly) different at baseline between groups, control-
ling for baseline severity did not alter the inferences.
The response to invitation, themixed locations of prac-
tices, the range of demographics, and the similarity to
observational cohorts3 should make these results gen-
eralisable. There was group differentiation in dipstick
use, midstream urine analysis, and the willingness of
women to delay the use of antibiotics, but a detailed
review of cases suggested that clinicians were likely to
want to do amidstreamurine test or document dipstick
results in a few patients irrespective of initial antibiotic
policy—sometimes because of patients’ expectation
(which might be expected to change over time as doc-
tors’ behaviour changes),6 sometimes for legitimate
clinical reasons (such as uncertainty about develop-
ment of complications), and occasionally because of
an overly optimistic view of the accuracy of dipsticks
(such as wanting adequate documentation, which
might bemisguided given the poor negative predictive
values of dipsticks).3 Estimates of effect were little
altered when these behaviours (that is, ordering mid-
stream urine analysis or dipstick documentation) were
included in the model, which suggests there was little
confounding of results by such behaviours.
Symptom control
The upper confidence intervals for the main outcome
(frequency symptoms) suggest that alternative strate-
gies are unlikely to result in poor symptom control
(around 18% worsening for the midstream urine or
delayed groups, and 2% in dipstick and symptom
score groups). There was some evidence that if
women waited more than 48 hour they reconsulted
less but had poorer control of symptoms, particularly
for the midstream urine group. The finding of worse
symptoms in such patients is in agreement with evi-
dence of the effect of antibiotics from observational
studies and trials.16 17 Why the delayed group who
waited a similar time did not have increased symp-
toms, however, is unclear. Thismight be a chance find-
ing, but it might be because women in the midstream
urine group find passively waiting for a laboratory
result to be more distressing than being given the free-
dom to choose when to stop the delay according to
their symptoms (the empirical delayed group). A pre-
vious study treated women negative for nitrite and
leucocyte esterase with antibiotics and found sympto-
matic benefit,18 but as about a third of women who
have negative results for all important dipstick tests
(that is, not only nitrite and leucocyte but also blood)
still have urinary tract infection based on rigorous
laboratory confirmation,3 the finding of a benefit in
women with negative dipstick results18 might be
expected. The poor negative predictive value of dip-
sticks suggests that the offer of some kind of antibiotic
safety net—such as delayed prescribing—to women
with negative dipstick results is reasonable.
Antibiotic use
A modest reduction in antibiotic use (20-25%) was
achieved in all groups except the symptom score
group. While these reductions are probably useful for
public health,19 and the effect might plausibly increase
Table 3 | Estimates of symptom duration (95% confidence interval) for women who delayed antibiotics by 48 hours or more
Duration of moderately bad symptoms in days
(negative binomial; incidence rate ratio)
Net effect of delaying
in each group*
Immediate antibiotics Incidence rate ratio set to 1.00
Midstream urine 0.82 (0.84 to 2.83) 1.73 (1.22 to 2.44)
Dipstick 0.84 (0.61 to 1.17) 1.20 (0.78 to 1.85)
Symptom score 1.13 (0.85 to 1.50) 0.96 (0.59 to 1.57)
Delayed 1.06 (0.74 to 1.51) 1.22 (0.88 to 1.68)
Taken on third day or later 1.54 (0.84 to 2.83) —
Interaction terms
Midstream urine/antibiotics taken on third day or later 1.37 (0.66 to 2.85) —
Dipstick/antibiotics taken on third day or later 0.92 (0.43 to 1.99) —
Symptom score/antibiotics taken on third day or later 0.55 (0.25 to 1.20) —
Delayed/antibiotics taken on third day or later 0.74 (0.36 to 1.53) —
*Net effect=effect in group×effect of taking after 3 days×interaction term for that group—for example, effect of delaying for more than 48 hours in
midstream urine group=0.82×1.54×1.37=1.73 .
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with time as patient expectations change,6 the magni-
tude of the effect is in contrast to delayed antibiotic
prescription among patients with respiratory
infections.5 13 This is perhaps not surprising given that
few respiratory infections are bacterial whereas most
suspected urinary tract infections are (66% of the mid-
stream urine group had confirmed infection, similar to
the previous study).3 There was some evidence that
delayed prescribingmight reduce reconsultation as we
hypothesised,6 but this was not significant, probably
because of the relatively low power of this analysis.
Use of midstream urine analysis
There was no evidence that either using midstream
urine analysis as an initial strategy to guide antibiotic
prescribing or the use of midstream urine samples by
doctors as part of their overall clinical management
made any difference to ordering analysis during fol-
low-up or other outcomes. As with antibiotic prescrib-
ing, as perceptions change among patients and doctors
regarding the need formidstreamurine analysis in clin-
ical management of uncomplicated infections, use of
laboratory resources for such an unnecessary investi-
gation could be significantly reduced.
Conclusion
All management strategies achieve similar symptom
control. There is no advantage in routinely sending
midstreamurine samples, and patients who delaywait-
ing for results of such analysis by more than 48 hours
might have poor symptom control. Antibiotics tar-
geted with dipstick tests with a delayed prescription
as backup, or empirical delayed prescription help
reduce antibiotic use.
We are grateful for the time given by patients and clinicians. We thank
Bayer for provision of the 8SG strips.
Contributors:PL and MVM had the original ideas for the study. All authors
developed the protocol. ST ran the study on a day to day basis, KR
managed the database. PL and MM performed the analysis: PL, MVM, and
MM are guarantors. All authors contributed to writing the paper
Funding: This study was funded by the Health Technology Programme of
UK NHS Research and Development. The researchers are independent of
the funders, and the funders were not involved in management or
analysis of the project.
Competing interests: JAL has been paid to attend consultancy workshops
by Bayer and is currently working in collaboration with Bayer in unpaid
capacity.
Ethical approval: This study was approved by the South West MReC
ethics committee and informed consent was given by all patients.
Data sharing: No additional data available; the authors are willing to share
data where appropriate—for example, for use in individual patient data
meta-analysis.
1 HMSO, OPCS. Morbidity statistics from general practice: fourth
national study 1991. 1st ed. HMSO, 1994.
2 Foxman B. Epidemiology of urinary tract infections: incidence,
morbidity, and economic costs. Dis Mon 2003;49:53-70.
3 Little P, Turner S, Rumsby K, Warner G, Moore M, Lowes A, et al.
Developing clinical rules to predict urinary tract infection in primary
care settings: sensitivity and specificity of near patient tests
(dipsticks) and clinical scores. Br J Gen Pract 2006;529:606-12.
4 Little P, Gould C, Williamson I, Warner G, Gantley M, Kinmonth A.
Clinical and psychological predictors of illness duration from
randomised controlled trial of prescribing strategies for sore throat.
BMJ 1999;319:736-7.
5 Little PS, Williamson I, Warner G, Gould C, Gantley M, Kinmonth AL.
An open randomised trial of prescribing strategies for sore throat.
BMJ 1997;314:722-7.
6 Little PS, Gould C, Williamson.I., Warner G, Gantley M, Kinmonth AL.
Reattendance and complications in a randomised trial of prescribing
strategies for sore throat: the medicalising effect of prescribing
antibiotics. BMJ 1997;315:350-2.
7 Dobbs FF, Fleming DM. A simple scoring system for evaluating
symptoms, history and urine dipstick testing in the diagnosis of
urinary tract infection. J R Coll Gen Pract 1987;37:100-4.
8 Watson L, Little P,Williamson I, MooreM,Warner G. Validation study
of a diary for use in acute lower respiratory tract infection. Fam Pract
2001;18:553-554.
9 Little PS, Williamson I, Warner G, Gould C, Gantley M, Kinmonth AL.
An open randomised trial of prescribing strategies for sore throat.
BMJ 1997;314:722-7.
10 Peveler R, Kilkenny L, Kinmonth A. Medically unexplained physical
symptoms in primary care: a comparison of self report screening
questionnaires and clinical opinion. J Psychosom Res
1997;42:245-52.
11 European Confederation of Laboratory Medicine. ECLM—European
Urinanalysis Group European analysis guidelines. Scand J Clin Lab
Invest 2000;60:1-96.
12 Little P, Griffin S, Kelly J, Dickson N, Sadler C. Effect of educational
leaflets and questions on knowledge of contraception in women
taking the combined oral contraceptive pill: randomised controlled
trial. BMJ 1998;316:1948-52.
13 Little P, Rumsby K, Kelly J, Watson L, Moore M, Warner G, et al.
Information leaflet and antibiotic prescribing strategies for acute
lower respiratory tract infection: a randomised controlled trial. JAMA
2005;293:3029-35.
14 Little P, Gould C, Williamson I, Moore M, Warner G, Dunleavey J. A
pragmatic randomised controlled trial of two prescribing strategies
for acute otitis media. BMJ 2001;322:336-42.
15 Little P, Kelly J, Barnett J, Dorward M, Warm D, Margetts B.
Randomised controlled factorial trial of dietary advice for patients
with a single high blood pressure reading in primary care. BMJ
2004;328:1054-60.
16 Christiaens T, DeMeyereM,VerschraegenG, PeersmanW,HeytensS,
DeMaeseneer J. Randomised controlled trial of nitrofurantoin versus
placebo in the treatment of uncomplicated urinary tract infection in
adult women. Br J Gen Pract 2002;52:729-34.
17 Little P, Merriman R, Turner S, Rumsby K, Warner G, Lowes JA, et al.
Presentation, pattern, and natural course of severe symptoms, and
role of antibiotics and antibiotic resistance among patients
presenting with suspected uncomplicated urinary tract infection in
primary care: observational study. BMJ
2010;doi:10.1136/bmj.b5633.
18 Richards D, Toop L, Chambers S, Fletcher L. Response to antibiotics
of women with symptoms of urinary tract infection but negative
dipstick urine test results: double blind randomised controlled trial.
BMJ 2005;331;143.
19 House of Lords Select Committee on Science and Technology: 7th
report. Occasional Report 1998.
WHAT IS ALREADY KNOWN ON THIS TOPIC
Urinary tract infection is distressing, and although antibiotics probably help symptoms, an
immediate antibiotic prescription might not always be necessary
We know of no trials comparing the commonly used management strategies of empirical
delayed prescribing, targeting by dipstick, targeting by symptom pattern, or waiting for the
midstream urine result
WHAT THIS STUDY ADDS
All management strategies achieve similar symptom control
There is no advantage to routinely sending midstream urine samples for testing
Antibiotics targeted with dipstick tests with a delayed prescription as backup, or empirical
delayed prescription, can help reduce antibiotic use
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